Belbin_2007 - Human Molecular Genetics, 2007, Vol. 16, No....

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer’s disease Olivia Belbin 1 , Janette L. Dunn 2 , Yan Ling 1 , Linda Morgan 1 , Sally Chappell 1 , Helen Beaumont 3 , Donald Warden 3 , David A. Smith 3 , Noor Kalsheker 1 and Kevin Morgan 1, * 1 Division of Clinical Chemistry, Institute of Genetics, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK, 2 School of Physics and Astronomy, University of Nottingham, University Park, Nottingham NG7 2RD, UK and 3 OPTIMA, Oxford Centre for Gene Function, Department of Physiology, Anatomy and Genetics, Oxford OX1 3PT, UK Received May 11, 2007; Revised and accepted June 28, 2007 The aim of this study was to investigate whether single nucleotide polymorphisms (SNPs) in the regulatory regions of the apolipoprotein E ( APOE ) gene modify the well-established 1 4-associated risk for Alzheimer’s disease (AD). Sequencing of the APOE gene regulatory regions revealed four previously reported promoter SNPs and one novel SNP in the previously described macrophage enhancer (ME.1). In addition, we also studied the two classic allelic missense SNPs that deFne 1 2/ 1 3/ 1 4 status in a case–control association study. Analysis of pair-wise linkage disequilibrium (LD) of the Fve regulatory region SNPs with classic APOE SNPs revealed a previously unreported 7 kb LD block covering the entire APOE gene, part of the pro- moter and 3 0 enhancer region. We report here that in a case–control association study ( N 5 719) of the seven SNPs, the genotype at codon 112 captures all the information required to assess disease risk. To explore cor- relations with quantitative traits, 169 patients were studied in whom rates of cognitive decline were available. In addition to the 1 4 allele, two regulatory region SNPs were associated with the rate of cognitive decline in AD patients. This study highlights the effect of APOE gene variation on risk of AD and rate of cognitive decline and demonstrates that a single SNP, which confers 1 4 status, captures all of the risk of developing AD but two SNPs in the regulatory region may affect the rate of cognitive decline in AD patients. INTRODUCTION Familial early-onset Alzheimer’s disease (AD) accounts for ± 5–10% of AD cases and most can be explained by inheri- tance of known mutations in amyloid precursor protein ( APP) and presenilins (PSEN) 1 and 2 genes in an autosomal dominant fashion (1). The remaining AD cases are associated with a later age at onset and represent ‘sporadic’ AD, although these sporadic cases may also have a signi±cant genetic com- ponent. Several genes have been implicated as potential candi- dates for this late-onset AD (LOAD) but the apolipoprotein ( APOE ) gene is the only one to date that has been replicated in numerous studies (2–4). The protein exists in three major isoforms apoE2, apoE3 and apoE4 that arise from three APOE alleles: APOE 1 2, APOE 3 and APOE 4 as a result of two missense single nucleotide polymorphisms (SNPs),
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 11/25/2009 for the course BI 379 taught by Professor Kavaler during the Spring '09 term at Colby.

Page1 / 10

Belbin_2007 - Human Molecular Genetics, 2007, Vol. 16, No....

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online